DMAQ
Deep Medicine Acquisition
DMAQ | NASDAQ
Chart Builder DCF Calculator
$2.96
-$5.43 (-64.72%)
At close: Jan 31, 2024, 04:00 PM ET

Deep Medicine Acquisition Company Profile

Company profile explained

Company Profile

Deep Medicine Acquisition Corp. (DMAQ) currently operates as a non-operating entity, possessing no substantial business functions of its own. Its express purpose is to execute a business combination, which could entail a merger, an acquisition of equity or assets, or a reorganization, with one or more target companies. The firm's strategic efforts are specifically concentrated on identifying promising enterprises within the healthcare industry. Incorporated in 2020, DMAQ maintains its principal place of business in New York, New York.

Key Executives

Name Position
Humphrey Polanen Chief Executive Officer & Chairman of the Board

Latest SEC Filings

Date Type Title
Sep 29, 2026 8-K Current Report
Sep 24, 2026 8-K Current Report
Sep 09, 2026 8-K Current Report
Aug 27, 2026 8-K Current Report
Aug 24, 2026 8-K Current Report
Aug 21, 2026 8-K Current Report
Aug 18, 2026 8-K Current Report
Aug 14, 2026 10-Q Quarterly Report
May 22, 2026 3 Filing
May 20, 2026 10-Q Quarterly Report
View All SEC Filings ➞
Deep Medicine Acquisition
DMAQ
Country United States
IPO Date Dec 2, 2021
Industry Shell Companies
Sector Financial Services
Employees 2
CEO Humphrey P. Polanen

Contact Details

595 Madison Avenue New York City, New York 10017 United States
n/a

Stock Details

Ticker Symbol DMAQ
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001857086
CUSIP Number 243733102
ISIN Number US2437331026
SIC Code 6770

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.